HIGHLIGHTS
- who: Benedikt Flörsch from the Department of Radiation Oncology, University Hospital, Germany have published the Article: Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis, in the Journal: (JOURNAL)
- what: The aim of this study was to further the understanding Fig 1 STROBE flowchart for patient accrual of treatment-associated parameters and to provide new impulses for scientific approaches and treatment patterns. The aim of this study was to compare oncological outcome in inoperable stage III NSCLC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.